Leased, 1,800 sq ft Quebec licensed micro cultivator on 32-acres for $200k OBO
Expansion-ready licensed micro cultivation facility on 32 acres offers low-cost entry into highly desirable Quebec market. Owner seeks full divestiture of the going-concern business, equipment and lease.
Listing ID:
5788077653
Licence(s) Held:
Micro Cultivation
Seeking outright divestiture of the going-concern business, equipment and lease for $200,000 obo.
Listing Details:
A1800 ft.² micro cultivation, leased facility in Quebec sitting on 32 acres of land
Site is fully licensed and currently operational
Facility is built out with 3 growing rooms, 50 sq meters canopy, plan to expand to 200 m2
Medical grade interior finishes
400A 600V electrical service
Second floor area available for extra space
Facility is available for lease at a reasonable rate
This site is ideal as a very low-cost entry point into the Quebec legal cannabis market
Very lean operating costs
The facility can be expanded to add additional canopy space (to the micro limit of 200 m2) or in the existing space for vertical growing
There is an option to purchase the land and building for $600,000
5788077653
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.